SCHEDULE: Marathon Micro Fund Reports 9.1% Stake in LiqTech

Marathon Micro Fund, LP has disclosed beneficial ownership of 3,000,000 shares, representing 9.1% of the outstanding common stock of LiqTech International Inc.

Summary

• Marathon Micro Fund, LP has filed a Schedule 13G, indicating it beneficially owns 3,000,000 shares of LiqTech International Inc. common stock.
• This holding represents 9.1% of the class of securities.
• The filing confirms Marathon Micro Fund, LP has sole voting power and sole dispositive power over these shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a significant ownership stake but provides no operational or financial performance data for LiqTech International Inc. itself.

Positives

• Marathon Micro Fund, LP has taken a significant stake, holding 9.1% of LiqTech International Inc. common stock.
• The fund possesses sole voting and dispositive power, indicating clear control over its investment.

Risks

• The filing does not explicitly detail risks associated with this investment, but any significant stake by an investment fund can be subject to market volatility and company performance risks.

Future Outlook

The filing does not contain forward-looking statements or guidance from LiqTech International Inc. It solely reports the ownership stake by Marathon Micro Fund, LP.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. Marathon Micro Fund's acquisition of 9.1% in LiqTech International Inc. suggests a notable level of confidence or strategic interest in the company's prospects within its sector.

Stakeholder Impact

• Shareholders: The acquisition of a significant stake by Marathon Micro Fund, LP may signal increased institutional interest, potentially influencing market perception and share price.
• Management: The filing indicates the investment is not for the purpose of influencing control, suggesting a passive or strategic investment rather than an activist approach.

Key Dates

Keywords

Schedule 13G, Marathon Micro Fund, LiqTech International Inc., beneficial ownership, common stock, investment, SEC filing